Skip to main content

Table 1 Characteristics of the patients studied

From: Total average diastolic longitudinal displacement by colour tissue doppler imaging as an assessment of diastolic function

 

Controls (n = 49)

Severe Systolic HF (n = 45)

LV Hypertrophy (n = 49)

LV Dilation (n = 30)

Mitral Regurgitation (n = 33)

Age, y

58 ± 15

65 ± 15*

69 ± 15***

76 ± 9***

71 ± 11***

Male sex, % (n)

43 (21)

93 (42)

47 (23)

57 (17)

55 (18)

Height, cm

173 ± 9

177 ± 9*

171 ± 10

167 ± 7**

171 ± 9

Weight, kg

76 ± 16

82 ± 15

73 ± 14

65 ± 14**

72 ± 15

LVIDd, cm

4.7 ± 0.6

5.6 ± 0.7***

5.2 ± 0.7**

6.8 ± 0.8***

5.0 ± 0.9

BSA, m2

1.9 ± 0.2

2.0 ± 0.2*

1.8 ± 0.2

1.7 ± 0.2***

1.8 ± 0.2

LVIDd/BSA, cm/m2

2.5 ± 0.3

2.9 ± 0.4***

2.8 ± 0.4***

4.0 ± 0.2***

2.7 ± 0.5*

LVEF, %

64 ± 7

30 ± 9***

60 ± 7*

25 ± 12***

53 ± 16***

IVS, cm

0.9 ± 0.2

0.9 ± 0.2

1.2 ± 0.2***

1.0 ± 0.2

1.0 ± 0.3

LVPWd, cm

0.9 ± 0.2

0.9 ± 0.2

1.2 ± 0.2***

1.0 ± 0.1

1.0 ± 0.3

LVM/BSA, g/m2

70 ± 16

102 ± 19***

130 ± 23***

171 ± 42***

103 ± 37**

DDF 0, % (n)

74 (36)

24 (11)

35 (17)

0 (0)

36 (12)

DDF 1, % (n)

22 (11)

51 (23)

39 (19)

47 (14)

24 (8)

DDF 2, % (n)

4 (2)

11 (5)

27 (13)

47 (14)

30 (10)

DDF 3, % (n)

0 (0)

13 (6)

0 (0)

7 (2)

9 (3)

E/A

1.2 ± 0.5

1.2 ± 0.8

1.1 ± 0.5

1.4 ± 1.0

1.5 ± 0.6**

DT, ms

221 ± 57

191 ± 98

236 ± 59

218 ± 66

223 ± 93

LAV, ml/m2

24.5 ± 9.0

33.8 ± 10.5***

39.6 ± 13.7***

45.5 ± 18.2***

46.5 ± 16.5***

E/e’

8.6 ± 3.6

12.3 ± 6.4**

12.4 ± 5.4***

17.0 ± 7.9***

19.3 ± 14.9***

Known IHD, % (n)

18 (9)

69 (31)

4 (2)

17 (5)

21 (7)

  1. HF heart failure, LV Left ventricular, LVIDd LV internal dimension in diastole, BSA body surface area, LVEF LV ejection fraction, IVS interventricular septum, LVPWd LV posterior wall in diastole, LVM LV mass, DDF degree of diastolic dysfunction, E/A early inflow velocity/atrial inflow velocity, DT deceleration time, LAV left atrial volume, E/e’ early inflow velocity/early diastolic tissue velocity, IHD ischemic heart disease
  2. *P <0.05 compared with the control group
  3. **P <0.01 compared with the control group
  4. ***P <0.001 compared with the control group